Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Neuropathic Pain Management market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Neuropathic Pain Managementmarket, defines the market attractiveness level of Neuropathic Pain Management market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Neuropathic Pain Management industry, describes the types of Neuropathic Pain Management market, the applications of major players and the market size, and deeply analyzes the current situation of the global Neuropathic Pain Management market and the development prospects and opportunities of Neuropathic Pain Management industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Neuropathic Pain Management market in Chapter 13.
By Player:
Pfizer
Sanofi
Eli Lilly and Company
GlaxoSmithKline
Johnson & Johnson Services
Biogen Idec
Bristol-Myers Squibb
Baxter Healthcare Corporation
Depomed
By Type:
Tricyclic Antidepressant
Anticonvulsant
Opioid
Steroid Drug
Local Anesthesia
Other
By End-User:
Retail Pharmacy
Hospital Pharmacy
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Neuropathic Pain Management Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Neuropathic Pain Management Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Neuropathic Pain Management Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Neuropathic Pain Management Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Neuropathic Pain Management Market Analysis and Outlook to 2022
-
7.1 Global Neuropathic Pain Management Consumption (2017-2022)
-
7.2 United States Neuropathic Pain Management Consumption (2017-2022)
-
7.3 Europe Neuropathic Pain Management Consumption (2017-2022)
-
7.4 China Neuropathic Pain Management Consumption (2017-2022)
-
7.5 Japan Neuropathic Pain Management Consumption (2017-2022)
-
7.6 India Neuropathic Pain Management Consumption (2017-2022)
-
7.7 South Korea Neuropathic Pain Management Consumption (2017-2022)
8 Region and Country-wise Neuropathic Pain Management Market Analysis and Outlook to 2028
-
8.1 Global Neuropathic Pain Management Consumption Forecast (2022-2028)
-
8.2 United States Neuropathic Pain Management Consumption Forecast (2022-2028)
-
8.3 Europe Neuropathic Pain Management Consumption Forecast (2022-2028)
-
8.4 China Neuropathic Pain Management Consumption Forecast (2022-2028)
-
8.5 Japan Neuropathic Pain Management Consumption Forecast (2022-2028)
-
8.6 India Neuropathic Pain Management Consumption Forecast (2022-2028)
-
8.7 South Korea Neuropathic Pain Management Consumption Forecast (2022-2028)
9 Global Neuropathic Pain Management Market Outlook by Types and Applications to 2022
-
9.1 Global Neuropathic Pain Management Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tricyclic Antidepressant Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anticonvulsant Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Opioid Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Steroid Drug Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Local Anesthesia Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Neuropathic Pain Management Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Neuropathic Pain Management Market Outlook by Types and Applications to 2028
-
10.1 Global Neuropathic Pain Management Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tricyclic Antidepressant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anticonvulsant Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Opioid Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Steroid Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Local Anesthesia Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Neuropathic Pain Management Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Neuropathic Pain Management Import and Export Analysis (Top 5 Countries)
-
11.1 Global Neuropathic Pain Management Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Neuropathic Pain Management Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Neuropathic Pain Management Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Neuropathic Pain Management Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Neuropathic Pain Management Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Neuropathic Pain Management Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Neuropathic Pain Management Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Neuropathic Pain Management Product and Service
-
14.5 Johnson & Johnson Services
-
14.5.1 Johnson & Johnson Services Company Details
-
14.5.2 Johnson & Johnson Services Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Services Neuropathic Pain Management Product and Service
-
14.6 Biogen Idec
-
14.6.1 Biogen Idec Company Details
-
14.6.2 Biogen Idec Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Biogen Idec Neuropathic Pain Management Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Neuropathic Pain Management Product and Service
-
14.8 Baxter Healthcare Corporation
-
14.8.1 Baxter Healthcare Corporation Company Details
-
14.8.2 Baxter Healthcare Corporation Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Baxter Healthcare Corporation Neuropathic Pain Management Product and Service
-
14.9 Depomed
-
14.9.1 Depomed Company Details
-
14.9.2 Depomed Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Depomed Neuropathic Pain Management Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Neuropathic Pain Management
-
Figure Neuropathic Pain Management Picture
-
Table Global Neuropathic Pain Management Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuropathic Pain Management Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Neuropathic Pain Management Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Neuropathic Pain Management Consumption by Country (2017-2022)
-
Figure United States Neuropathic Pain Management Consumption and Growth Rate (2017-2022)
-
Table Europe Neuropathic Pain Management Consumption and Growth Rate (2017-2022)
-
Figure China Neuropathic Pain Management Consumption and Growth Rate (2017-2022)
-
Figure Japan Neuropathic Pain Management Consumption and Growth Rate (2017-2022)
-
Figure India Neuropathic Pain Management Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neuropathic Pain Management Consumption and Growth Rate (2017-2022)
-
Figure Global Neuropathic Pain Management Consumption Forecast by Country (2022-2028)
-
Figure United States Neuropathic Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neuropathic Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Neuropathic Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neuropathic Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neuropathic Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neuropathic Pain Management Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tricyclic Antidepressant Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsant Consumption and Growth Rate (2017-2022)
-
Figure Global Opioid Consumption and Growth Rate (2017-2022)
-
Figure Global Steroid Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Local Anesthesia Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tricyclic Antidepressant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticonvulsant Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Opioid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroid Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Local Anesthesia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Neuropathic Pain Management Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Neuropathic Pain Management Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neuropathic Pain Management Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neuropathic Pain Management Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Neuropathic Pain Management Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Neuropathic Pain Management Product and Service
-
Table Johnson & Johnson Services (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services Neuropathic Pain Management Product and Service
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Neuropathic Pain Management Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Neuropathic Pain Management Product and Service
-
Table Baxter Healthcare Corporation (Foundation Year, Company Profile and etc.)
-
Table Baxter Healthcare Corporation Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Healthcare Corporation Neuropathic Pain Management Product and Service
-
Table Depomed (Foundation Year, Company Profile and etc.)
-
Table Depomed Neuropathic Pain Management Sales, Price, Value and Gross Profit (2017-2022)
-
Table Depomed Neuropathic Pain Management Product and Service
-
